Healthcare AI Acquisition ^{Priced, Nasdaq: HAIAU}

We are a newly formed blank check company. We were founded by Stanley Capital, an independent investment firm focused on the growing sustainable investment sectors of healthcare, technology and resource efficiency. We intend to capitalize on the multiple decades of combined investment experience of our management and board of directors to identify and acquire a business that we believe provides opportunities for attractive risk-adjusted returns in the healthcare and pharmaceutical sector with technological transformation potential. Stanley Capital was founded by senior investment professionals Simon Cottle, James Brooks and Patrick Hargutt. The team has a proven track record of actively delivering value creation, investing in and managing transactions with equity invested totaling approximately $3.7 billion. Over their careers, the team delivered an aggregate internal rate of return (“IRR”) of 89% and a multiple on invested capital (“MOIC”) of 3.4x on 25 investments. The team has built sector-leading businesses specifically in healthcare (Noden Pharma, Essential Pharma, Envision Pharma), technology and technology-enabled services (Parts Alliance, Zenith Leasedrive and Mach), and resource efficiency (Lightsource BP).